1. Radiofrequency ablation for hepatocellular carcinoma
   Hiroki Nishikawa et al, 2013, International Journal of Hyperthermia CrossRef
2. Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis
   Shuling Chen et al, 2018, BMC Cancer CrossRef
3. Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis
   Takamasa Ohki et al, 2015, Clinical Drug Investigation CrossRef
4. Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease
   Martha M Kirstein et al, 2018, United European Gastroenterology Journal CrossRef
5. A retrospective study of initial dose of sorafenib therapy in Japanese patients with unresectable hepatocellular carcinoma -experiences from a single center
   Haruhiko Takeda et al, 2013, Kanzo CrossRef
6. Clinical significance of therapy using branched‐chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma
   Hiroki Nishikawa et al, 2014, Hepatology Research CrossRef
7. Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization
   Shu-Jung Hsu et al, 2021, Academic Radiology CrossRef
8. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization
   Yanfang Wu et al, 2022, Medicina CrossRef
9. Multidisciplinary collaboration for the successful treatment of a giant hepatic solitary fibrous tumor protruding into the thorax: A case report
   Jiajun Lin et al, 2022, Experimental and Therapeutic Medicine CrossRef
10. Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
    Jihye Kim et al, 2019, PLOS ONE CrossRef
11. Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization
    L. Zhu et al, 2018, Clinical and Translational Oncology CrossRef
12. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis
    Zhoujing Cheng et al, 2020, World Journal of Surgical Oncology CrossRef